News & Events
Peptech realises A$178m with Domantis sale completion
08 / 01 / 2007
Key Points - GSK's acquisition of Domantis completed - Peptech share of gross proceeds is GBP 71.3 million (approximately A$178 million or $1.08 per share) - Peptech realises a A$138.2 million gain from an investment of A$40.2 million -…
Displaying records 51-51 of 51